Building a better understanding of Low-Grade ovarian cancer
NCT ID NCT00488878
First seen Jun 24, 2026 · Last updated Aug 11, 2026 · Updated 3 times
Summary
This study gathers medical records and leftover tissue samples from up to 2,000 people with low-grade ovarian or peritoneal tumors. The goal is to create a detailed database that helps researchers learn more about these rare cancers and how they are treated. No new drugs or procedures are being tested; this is purely an information-gathering effort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this database could help researchers identify patterns and develop better treatments for low-grade ovarian and peritoneal cancers.
- What could go wrong
- This is an observational data collection study, not a treatment trial. It does not test any new therapy, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW GRADE OVARIAN SEROUS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can heated chemotherapy improve ovarian cancer outcomes?
- Can a Two-Drug combo keep fighting a rare ovarian cancer?
- Can engineered immune cells target a common ovarian cancer protein?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Experimental pill takes on Hard-to-Treat ovarian cancer
- Targeted drug hunts down cancer cells in advanced bladder cancer trial